203641 | BMP-2, Human, Recombinant, E. coli

203641
Price could not be retrieved
Minimum Quantity needs to be mulitiple of
Upon Order Completion More Information
You Saved ()
 
Request Pricing
Limited AvailabilityLimited Availability
Stocked 
Discontinued
Limited Quantities Available
Available
    Remaining : Will advise
      Remaining : Will advise
      Will advise
      Contact Customer Service
      View Pricing & Availability
      Click To Print This Page

      Overview

      Replacement Information

      Key Specifications Table

      Purity
      ≥95% by SDS-PAGE

      Pricing & Availability

      Catalog NumberAvailability Packaging Qty/Pack Price Quantity
      203641-2UG
      Retrieving availability...
      Limited AvailabilityLimited Availability
      Stocked 
      Discontinued
      Limited Quantities Available
      Available
        Remaining : Will advise
          Remaining : Will advise
          Will advise
          Contact Customer Service

          Plastic ampoule 2 μg
          Retrieving price...
          Price could not be retrieved
          Minimum Quantity needs to be mulitiple of
          Upon Order Completion More Information
          You Saved ()
           
          Request Pricing
          Description
          OverviewRecombinant, human bone morphogenetic protein-2 (BMP-2) expressed in E. coli and purified by proprietary chromatographic methods. BMP-2 is a homodimeric protein that belongs to the transforming growth factor-β (TGF-β) superfamily. BMP-2 is known to regulate diverse fundamental processes during embryonic development. It also plays an important role in cardiac morphogenesis and is expressed in a variety of tissues such as lung, spleen, brain, liver, prostate, ovary, and small intestine.
          Catalogue Number203641
          Brand Family Calbiochem®
          SynonymsBone morphogenetic protein 2 precursor, BMP-2A
          References
          ReferencesCsiszar, A., et al. 2006. Am. J. Pathol. 168, 629.
          Kumagai, T., et al. 2006. Anticancer Res. 26, 293.
          Kumagai, T., et al. 2006. Int. J. Mol. Med. 17, 285.
          Kuo, P.L., et al. 2006. Biol. Pharm. Bull. 29, 119.
          Morin, R., et al. 2006. Biomacromolecules 7, 131.
          Villavicencio, A.T., et al. 2005. J. Neurosurg. Spine 3, 436.
          Product Information
          FormLyophilized
          FormulationLyophilized from sterile 10 mM sodium citrate, pH 3.5.
          Applications
          Biological Information
          Purity≥95% by SDS-PAGE
          Physicochemical Information
          Dimensions
          Materials Information
          Toxicological Information
          Safety Information according to GHS
          Safety Information
          Product Usage Statements
          Storage and Shipping Information
          Ship Code Blue Ice Only
          Toxicity Standard Handling
          Storage -20°C
          Do not freeze Ok to freeze
          Special InstructionsFollowing reconstitution, refrigerate (4°C) for short-term storage or aliquot and freeze (-20°C) for long-term storage. Stock solutions are stable for 2-7 days at 4°C or for up to 6 months at -20°C. Avoid freeze/thaw cycles of solutions.
          Packaging Information
          Transport Information
          Supplemental Information
          Specifications

          Documentation

          Certificates of Analysis

          TitleLot Number
          203641

          References

          Reference overview
          Csiszar, A., et al. 2006. Am. J. Pathol. 168, 629.
          Kumagai, T., et al. 2006. Anticancer Res. 26, 293.
          Kumagai, T., et al. 2006. Int. J. Mol. Med. 17, 285.
          Kuo, P.L., et al. 2006. Biol. Pharm. Bull. 29, 119.
          Morin, R., et al. 2006. Biomacromolecules 7, 131.
          Villavicencio, A.T., et al. 2005. J. Neurosurg. Spine 3, 436.

          Brochure

          Title
          Biologics 32.3 PDF ( 927 KB )
          Biologics 32.4 ( 1.19 MB )
          Data Sheet

          Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

          Revision20-May-2008 RFH
          SynonymsBone morphogenetic protein 2 precursor, BMP-2A
          DescriptionRecombinant, human bone morphogenetic protein-2 (BMP-2) expressed in E. coli and purified by proprietary chromatographic methods. BMP-2 is a homodimeric protein that belongs to the transforming growth factor-β (TGF-β) superfamily. BMP-2 is known to regulate diverse fundamental processes during embryonic development. It also plays an important role in cardiac morphogenesis and is expressed in a variety of tissues such as lung, spleen, brain, liver, prostate, ovary, and small intestine.
          FormLyophilized
          FormulationLyophilized from sterile 10 mM sodium citrate, pH 3.5.
          Purity≥95% by SDS-PAGE
          SolubilityReconstitute to ≥100 µg/ml with 20 mM acetic acid containing 0.1% HSA or BSA. Further dilutions can be made in aqueous buffers just prior to use.
          Storage -20°C
          Do Not Freeze Ok to freeze
          Special InstructionsFollowing reconstitution, refrigerate (4°C) for short-term storage or aliquot and freeze (-20°C) for long-term storage. Stock solutions are stable for 2-7 days at 4°C or for up to 6 months at -20°C. Avoid freeze/thaw cycles of solutions.
          Toxicity Standard Handling
          ReferencesCsiszar, A., et al. 2006. Am. J. Pathol. 168, 629.
          Kumagai, T., et al. 2006. Anticancer Res. 26, 293.
          Kumagai, T., et al. 2006. Int. J. Mol. Med. 17, 285.
          Kuo, P.L., et al. 2006. Biol. Pharm. Bull. 29, 119.
          Morin, R., et al. 2006. Biomacromolecules 7, 131.
          Villavicencio, A.T., et al. 2005. J. Neurosurg. Spine 3, 436.